Collaborations, Competitor News

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

Posted on

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ — Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc for the treatment of chronic myeloid leukemia (CML) and acute lymphatic leukemia (ALL). While maintaining financial and strategic control, Xspray Pharma will grant…

Academic, AI, Collaborations, Competitor News

Delve Health and UW Medicine Announce a Collaboration to Access Remote Data Capture for Diabetes Research

Posted on

MINNEAPOLIS, Feb. 22, 2023 /PRNewswire/ — Delve Health and UW Medicine are announcing a collaboration to provide new insights into endemic Type 2 Diabetes research, through artificial intelligence and machine learning (i.e., AI/ML) and remote data capture via Delve Health’s digital healthcare platform. Delve Health’s Clinical StudyPal, a mobile and web-based platform…

Collaborations, Competitor News, Data Partnership

REAT-NMD, a Leading Global NeuroMuscular Diseases Registry Network, and Aetion Announce Partnership on Real-World Evidence

Posted on

Collaboration will leverage global patient registries to deliver real-world evidence across rare neuromuscular diseases to biopharmaceutical companies NEW YORK and NEWCASTLE, England, Feb. 22, 2023 /PRNewswire/ — TREAT-NMD Services Ltd, the business arm of TREAT-NMD Alliance Ltd, a charity focused on neuromuscular disorders, and Aetion, Inc., the global leader in real-world evidence (RWE) technology…

Academic, Asia-Pacific, Collaborations, Competitor News, International

Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand

Posted on

Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health Group, Australia’s specialist health and medical research consulting, growth, risk, and clinical advisory group. The…

Competitor News

In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)

Posted on

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 21, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has extended and expanded the observational EFRONT Study to advance the genetic understanding of frontotemporal dementia (FTD). The…

AI, Competitor News, HR

PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy

Posted on

Nick Anderson, Ph.D., joins as Vice President of Regulatory Affairs andHisani Madison, Ph.D., MPH, joins as Franchise Head of Precision Oncology February 16, 2023 10:00 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced that Nick Anderson, Ph.D., has joined…

Collaborations, Competitor News, Data Partnership, Oncology

M2GEN and Zephyr AI Announce Partnership to Better Identify Treatments and Cures for Patients with Cancer

Posted on

February 16, 2023 06:29 AM Eastern Standard Time TAMPA, Fla. & TYSONS, Va.–(BUSINESS WIRE)–M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, and Zephyr AI, Inc. (“Zephyr AI”), a company building novel transparent AI to address unmet needs across the full spectrum of precision medicine – from…